The authors proposed that the DSD observed in 46,XY carriers of the GATA4 mutation was due to a loss-of-function effect on GATA4 in the developing gonad, interfering with its ability to interact with FOG2 and disturbing activation of the AMH promoter together with NR5A1. The gene discussed is GATA4; the disease is disorder of sexual differentiation.